0001022079-18-000133.txt : 20180529 0001022079-18-000133.hdr.sgml : 20180529 20180529163726 ACCESSION NUMBER: 0001022079-18-000133 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180525 FILED AS OF DATE: 20180529 DATE AS OF CHANGE: 20180529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GUINAN MARK CENTRAL INDEX KEY: 0001505998 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 18865001 MAIL ADDRESS: STREET 1: C/O QUEST DIAGNOSTICS STREET 2: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 4 1 wf-form4_152762623294219.xml FORM 4 X0306 4 2018-05-25 0 0001022079 QUEST DIAGNOSTICS INC DGX 0001505998 GUINAN MARK 500 PLAZA DRIVE SECAUCUS NJ 07094 0 1 0 0 Executive Vice President & CFO Common Stock 2018-05-25 4 M 0 61533 58.365 A 119733 D Common Stock 2018-05-25 4 S 0 36573 105.418 D 83160 D Common Stock 2018-05-25 4 S 0 24960 106.139 D 58200 D Stock Options (Right to Buy) 58.365 2018-05-25 4 M 0 61533 58.365 D 2023-08-19 Common Stock 61533.0 0 D This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 22, 2018. This transaction was executed in multiple trades at prices ranging from $105.00 to $105.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $106.00 to $106.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The options vested in three equal annual installments beginning with the first on August 19, 2014, the second on August 19, 2015 and the final on August 19, 2016. /s/ William J. O'Shaughnessy, Jr., attorney-in-fact for Mark J. Guinan 2018-05-29